Abiopharma

New SEC Form for ResMed Inc.

Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study

Pasithea Therapeutics Announces Positive PAS-004 Tablet Pharmacokinetic (PK) Data in Ongoing Phase 1/1b Trial in Adult NF1 Patients

Pasithea Therapeutics Announces Positive PAS-004 Tablet Pharmacokinetic (PK) Data in Ongoing Phase 1/1b Trial in Adult NF1 Patients

Shuttle Pharmaceuticals Acquires AI Health Platform

Favorable Pricing Certificates Issued for Evofems PHEXX by Emirates Drug Establishment are Launching Step for Commercialization in UAE

MAIA Biotechnology Highlights Ongoing Momentum of Ateganosine Clinical Program at SITC 2025

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit - DXCM

Citius Oncology - Citius Oncology to Advance Commercial Launch ofLYMPHIR™ with Verix AI Integration